Safety and efficacy of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma

Efficacy and safety of selpercatinib in RET fusion-positive cancers other than lung or thyroid cancers

First-line pembrolizumab plus chemotherapy for patients with advanced squamous NSCLC: 3-year follow-up from KEYNOTE-407

MERMAID-2: Phase 3 study of durvalumab in patients with resected stage MRD II-III NSCLC

Cemiplimab plus ipilimumab for advanced NSCLC

Highlights from AORTIC Cancer Genomics Conference 2021

The Conquering Cancer Campaign

Managing the treatment of NSCLC patients during the COVID-19 pandemic (FR)

Managing the treatment of NSCLC patients during the COVID-19 pandemic (DE)

Managing the treatment of NSCLC patients during the COVID-19 pandemic (IT)

Managing the treatment of NSCLC patients during the COVID-19 pandemic (ES)

Cabozantinib most effective treatment for metastatic papillary kidney cancer